Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Pre-Exposure Prophylaxis Integration into Family Planning Services at Title X Clinics in the Southeastern United States: A Geographically-Targeted Mixed Methods Study (Phase 1 ATN 155).

Sales JM, Escoffery C, Hussen SA, Haddad LB, Phillips A, Filipowicz T, Sanchez M, McCumber M, Rupp B, Kwiatkowski E, Psioda MA, Sheth AN.

JMIR Res Protoc. 2019 May 6;8(6):e12774. doi: 10.2196/12774.

2.

Improved Perinatal and Postpartum Human Immunodeficiency Virus Outcomes After Use of a Perinatal Care Coordination Team.

Hackett S, Badell ML, Meade CM, Davis JM, Blue J, Curtin L, Camacho-Gonzalez A, Chahroudi A, Chakraborty R, Nguyen MLT, Palmore MP, Sheth AN.

Open Forum Infect Dis. 2019 Apr 9;6(6):ofz183. doi: 10.1093/ofid/ofz183. eCollection 2019 Jun.

3.

Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study.

Shibeshi W, Sheth AN, Admasu A, Berha AB, Negash Z, Yimer G.

BMC Pharmacol Toxicol. 2019 May 23;20(1):31. doi: 10.1186/s40360-019-0313-y.

4.

A Multicenter Analysis of Elvitegravir Use During Pregnancy on HIV Viral Suppression and Perinatal Outcomes.

Badell ML, Sheth AN, Momplaisir F, Rahangdale L, Potter J, Woodham PC, Lazenby GB, Short WR, Gillespie SE, Baldreldin N, Miller ES, Alleyne G, Duthely LM, Allen SM, Levison J, Chakraborty R; HOPES (HIV and OB Pregnancy Education Study) Group.

Open Forum Infect Dis. 2019 Mar 18;6(4):ofz129. doi: 10.1093/ofid/ofz129. eCollection 2019 Apr.

5.

Low Rate of Sex-specific Analyses in Presentations at the Conference on Retroviruses and Opportunistic Infections (CROI) Meeting, 2018: Room to Improve.

Gandhi M, Smeaton LM, Vernon C, Scully EP, Gianella S, Poongulali S, Sheth AN, Van Schalkwyk M, Klingman KL, Short WR, Opollo VS, Cohn SE, Scarsi KK, Firnhaber C, Bares S, Swaminathan S, Mngqibisa R, Connick E; Womenʼs Health Inter-Network Scientific Committee (WHISC).

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):e158-e160. doi: 10.1097/QAI.0000000000002073. No abstract available.

PMID:
31021991
6.

Brief Report: Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia.

Sales JM, Cwiak C, Haddad LB, Phillips A, Powell L, Tamler I, Sheth AN.

J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):414-418. doi: 10.1097/QAI.0000000000002057.

PMID:
30985558
7.

HIV Care Continuum among Postpartum Women Living with HIV in Atlanta.

Meade CM, Badell M, Hackett S, Mehta CC, Haddad LB, Camacho-Gonzalez A, Ford J, Holstad MM, Armstrong WS, Sheth AN.

Infect Dis Obstet Gynecol. 2019 Feb 14;2019:8161495. doi: 10.1155/2019/8161495. eCollection 2019.

8.

Patient recommendations for PrEP information dissemination at family planning clinics in Atlanta, Georgia.

Sales JM, Phillips AL, Tamler I, Munoz T, Cwiak C, Sheth AN.

Contraception. 2019 Apr;99(4):233-238. doi: 10.1016/j.contraception.2018.12.008. Epub 2019 Jan 31.

PMID:
30711352
9.

Brief Report: PrEP Eligibility Among At-Risk Women in the Southern United States: Associated Factors, Awareness, and Acceptability.

Patel AS, Goparaju L, Sales JM, Mehta CC, Blackstock OJ, Seidman D, Ofotokun I, Kempf MC, Fischl MA, Golub ET, Adimora AA, French AL, DeHovitz J, Wingood G, Kassaye S, Sheth AN.

J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):527-532. doi: 10.1097/QAI.0000000000001950.

10.

Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.

Hynes JS, Sheth AN, Lathrop E, Sales JM, Haddad LB.

J Womens Health (Larchmt). 2019 May;28(5):665-672. doi: 10.1089/jwh.2018.7001. Epub 2019 Jan 4.

PMID:
30615569
11.

Associations Among Perceived HIV Risk, Behavioral Risk and Interest in PrEP Among Black Women in the Southern US.

Sales JM, Sheth AN.

AIDS Behav. 2019 Jul;23(7):1871-1876. doi: 10.1007/s10461-018-2333-9.

PMID:
30387025
12.

Sexually acquired acute hepatitis C infection diagnosed during pregnancy: a case report of successful postpartum treatment.

Nandi P, Kalapila AG, Badell ML, Sheth AN.

Case Rep Womens Health. 2018 Sep 19;20:e00080. doi: 10.1016/j.crwh.2018.e00080. eCollection 2018 Oct.

13.

Parenting Desires Among Individuals Living With Human Immunodeficiency Virus in the United States.

Cohn SE, Haddad LB, Sheth AN, Hayford C, Chmiel JS, Janulis PF, Schmandt J.

Open Forum Infect Dis. 2018 Sep 15;5(10):ofy232. doi: 10.1093/ofid/ofy232. eCollection 2018 Oct.

14.

Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial.

Gandhi M, Bacchetti P, Ofokotun I, Jin C, Ribaudo HJ, Haas DW, Sheth AN, Horng H, Phung N, Kuncze K, Okochi H, Landovitz RJ, Lennox J, Currier JS; AIDS Clinical Trials Group (ACTG) 5257 Study Team.

Clin Infect Dis. 2019 Mar 5;68(6):1044-1047. doi: 10.1093/cid/ciy764.

PMID:
30184104
15.

PrEP Eligibility and Interest Among Clinic- and Community-Recruited Young Black Women in Atlanta, Georgia, USA.

Sales JM, Steiner RJ, Brown JL, Swartzendruber A, Patel AS, Sheth AN.

Curr HIV Res. 2018;16(3):250-255. doi: 10.2174/1570162X16666180731143756.

16.

HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapy.

Lahiri CD, Brown NL, Ryan KJ, Acosta EP, Sheth AN, Mehta CC, Ingersoll J, Ofotokun I.

AIDS. 2018 Sep 24;32(15):2151-2159. doi: 10.1097/QAD.0000000000001945.

PMID:
30005011
17.

Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.

Radtke KK, Bacchetti P, Anastos K, Merenstein D, Crystal H, Karim R, Weber KM, Edmonds A, Sheth AN, Fischl MA, Vance D, Greenblatt RM, Rubin LH.

J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):202-208. doi: 10.1097/QAI.0000000000001658.

18.

The association of C-reactive protein with subclinical cardiovascular disease in HIV-infected and HIV-uninfected women.

Moran CA, Sheth AN, Mehta CC, Hanna DB, Gustafson DR, Plankey MW, Mack WJ, Tien PC, French AL, Golub ET, Quyyumi A, Kaplan RC, Ofotokun I.

AIDS. 2018 May 15;32(8):999-1006. doi: 10.1097/QAD.0000000000001785.

19.

T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts.

Titanji K, Vunnava A, Foster A, Sheth AN, Lennox JL, Knezevic A, Shenvi N, Easley KA, Ofotokun I, Weitzmann MN.

AIDS. 2018 Apr 24;32(7):885-894. doi: 10.1097/QAD.0000000000001764.

20.

Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry.

Phung N, Kuncze K, Okochi H, Louie A, Benet LZ, Ofokotun I, Haas DW, Currier JS, Chawana TD, Sheth AN, Bacchetti P, Gandhi M, Horng H.

Rapid Commun Mass Spectrom. 2018 Mar 15;32(5):431-441. doi: 10.1002/rcm.8058.

21.

Long term engagement in HIV care among postpartum women with perinatal HIV infection in the United States.

Meade CM, Hussen SA, Momplaisir F, Badell M, Hackett S, Sheth AN.

AIDS Care. 2018 Apr;30(4):488-492. doi: 10.1080/09540121.2017.1417531. Epub 2017 Dec 18.

22.

Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.

Hynes JS, Sales JM, Sheth AN, Lathrop E, Haddad LB.

Contraception. 2018 Mar;97(3):277-284. doi: 10.1016/j.contraception.2017.10.006. Epub 2017 Oct 18.

23.

The Female Genital Tract Microbiome Is Associated With Vaginal Antiretroviral Drug Concentrations in Human Immunodeficiency Virus-Infected Women on Antiretroviral Therapy.

Donahue Carlson R, Sheth AN, Read TD, Frisch MB, Mehta CC, Martin A, Haaland RE, Patel AS, Pau CP, Kraft CS, Ofotokun I.

J Infect Dis. 2017 Nov 15;216(8):990-999. doi: 10.1093/infdis/jix420.

24.

Successful Treatment of Azole-Resistant Candida Esophagitis in an Immunocompromised Pregnant Woman Using Anidulafungin.

Blackwell CO, Sheth AN, Nguyen ML, Badell ML.

Ann Pharmacother. 2017 Nov;51(11):1033-1034. doi: 10.1177/1060028017717998. Epub 2017 Jun 29. No abstract available.

PMID:
28660773
25.

Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative women.

Iyer SS, Sabula MJ, Mehta CC, Haddad LB, Brown NL, Amara RR, Ofotokun I, Sheth AN.

PLoS One. 2017 Jun 1;12(6):e0178193. doi: 10.1371/journal.pone.0178193. eCollection 2017.

26.

HIV and reproductive healthcare in pregnant and postpartum HIV-infected women: adapting successful strategies.

Rimawi BH, Smith SL, Badell ML, Zahedi-Spung LD, Sheth AN, Haddad L, Chakraborty R.

Future Virol. 2016 Aug;11(8):577-581. doi: 10.2217/fvl-2016-0065. Epub 2016 Aug 5.

27.

Management of Infected Total Knee Arthroplasty by a New Innovative Customized Articulating Knee Spacer: An Early Experience.

Marothi DP, Sharma V, Sheth AN, Shah VI, Bharath L, Pachore JA.

J Orthop Case Rep. 2016 Sep-Oct;6(4):20-22. doi: 10.13107/jocr.2250-0685.552.

28.

HIV pre-exposure prophylaxis for women.

Sheth AN, Rolle CP, Gandhi M.

J Virus Erad. 2016 Jul 1;2(3):149-55.

29.

Progesterone Levels Associate with a Novel Population of CCR5+CD38+ CD4 T Cells Resident in the Genital Mucosa with Lymphoid Trafficking Potential.

Swaims-Kohlmeier A, Haaland RE, Haddad LB, Sheth AN, Evans-Strickfaden T, Lupo LD, Cordes S, Aguirre AJ, Lupoli KA, Chen CY, Ofotukun I, Hart CE, Kohlmeier JE.

J Immunol. 2016 Jul 1;197(1):368-76. doi: 10.4049/jimmunol.1502628. Epub 2016 May 27.

30.

A Single-dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-induced Bone Loss in Treatment-naive HIV-infected Patients: A Phase IIb Trial.

Ofotokun I, Titanji K, Lahiri CD, Vunnava A, Foster A, Sanford SE, Sheth AN, Lennox JL, Knezevic A, Ward L, Easley KA, Powers P, Weitzmann MN.

Clin Infect Dis. 2016 Sep 1;63(5):663-671. doi: 10.1093/cid/ciw331. Epub 2016 May 18.

31.

Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection.

Ofotokun I, Titanji K, Vunnava A, Roser-Page S, Vikulina T, Villinger F, Rogers K, Sheth AN, Lahiri CD, Lennox JL, Weitzmann MN.

AIDS. 2016 Jan 28;30(3):405-14. doi: 10.1097/QAD.0000000000000918.

32.

Spontaneous Pneumothoraces due to Metastatic Endometrial Stromal Sarcoma in a Woman Infected with HIV.

Shah DJ, Phadke VK, Oprea-Ilies G, Berkowitz EA, Nguyen ML, Sheth AN.

Am J Respir Crit Care Med. 2016 Jan 1;193(1):96-7. doi: 10.1164/rccm.201505-0892IM. No abstract available.

33.

Antiretroviral Regimen Durability and Success in Treatment-Naive and Treatment-Experienced Patients by Year of Treatment Initiation, United States, 1996-2011.

Sheth AN, Ofotokun I, Buchacz K, Armon C, Chmiel JS, Hart RL, Baker R, Brooks JT, Palella FJ Jr.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):47-56. doi: 10.1097/QAI.0000000000000813.

34.

Complex Type 2 Reactions in Three Patients with Hansen's Disease from a Southern United States Clinic.

Leon KE, Salinas JL, McDonald RW, Sheth AN, Fairley JK.

Am J Trop Med Hyg. 2015 Nov;93(5):1082-6. doi: 10.4269/ajtmh.15-0052. Epub 2015 Aug 24.

35.

Cerebrospinal fluid concentrations of tenofovir and emtricitabine in the setting of HIV-1 protease inhibitor-based regimens.

Lahiri CD, Reed-Walker K, Sheth AN, Acosta EP, Vunnava A, Ofotokun I.

J Clin Pharmacol. 2016 Apr;56(4):492-6. doi: 10.1002/jcph.612. Epub 2015 Oct 20. No abstract available.

36.

Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients.

Lahiri CD, Tao S, Jiang Y, Sheth AN, Acosta EP, Marconi VC, Armstrong WS, Schinazi RF, Vunnava A, Sanford S, Ofotokun I.

AIDS. 2015 Jun 1;29(9):1113-5. doi: 10.1097/QAD.0000000000000659.

37.

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection.

Titanji K, Vunnava A, Sheth AN, Delille C, Lennox JL, Sanford SE, Foster A, Knezevic A, Easley KA, Weitzmann MN, Ofotokun I.

PLoS Pathog. 2014 Nov 13;10(10):e1004497. doi: 10.1371/journal.ppat.1004497. eCollection 2014 Oct.

38.

Contraceptive methods and risk of HIV acquisition or female-to-male transmission.

Haddad LB, Polis CB, Sheth AN, Brown J, Kourtis AP, King C, Chakraborty R, Ofotokun I.

Curr HIV/AIDS Rep. 2014 Dec;11(4):447-58. doi: 10.1007/s11904-014-0236-6. Review.

39.

Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations.

Delille CA, Pruett ST, Marconi VC, Lennox JL, Armstrong WS, Arrendale RF, Sheth AN, Easley KA, Acosta EP, Vunnava A, Ofotokun I.

J Clin Pharmacol. 2014 Sep;54(9):1063-71. doi: 10.1002/jcph.298. Epub 2014 Apr 8.

40.

HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.

Sheth AN, Evans-Strickfaden T, Haaland R, Martin A, Gatcliffe C, Adesoye A, Omondi MW, Lupo LD, Danavall D, Easley K, Chen CY, Pau CP, Hart C, Ofotokun I.

J Infect Dis. 2014 Sep 1;210(5):736-44. doi: 10.1093/infdis/jiu166. Epub 2014 Mar 18.

41.

Hip arthroplasty in failed intertrochanteric fractures in elderly.

Pachore JA, Shah VI, Sheth AN, Shah KP, Marothi DP, Puri R.

Indian J Orthop. 2013 Nov;47(6):572-7. doi: 10.4103/0019-5413.121581.

42.

Integrated population pharmacokinetic/viral dynamic modelling of lopinavir/ritonavir in HIV-1 treatment-naïve patients.

Wang K, D'Argenio DZ, Acosta EP, Sheth AN, Delille C, Lennox JL, Kerstner-Wood C, Ofotokun I.

Clin Pharmacokinet. 2014 Apr;53(4):361-71. doi: 10.1007/s40262-013-0122-1.

43.

Cri du chat syndrome: a series of five cases.

Dangare HM, Oommen SP, Sheth AN, Koshy B, Roshan R, Thomas MM, Danda S, Srivastava VM.

Indian J Pathol Microbiol. 2012 Oct-Dec;55(4):501-5. doi: 10.4103/0377-4929.107791.

44.

Uptake of tenofovir and emtricitabine into non-monocytic female genital tract cells with and without hormonal contraceptives.

James AM, King JR, Ofotokun I, Sheth AN, Acosta EP.

J Exp Pharmacol. 2013 Aug 1;5:55-64. doi: 10.2147/JEP.S45308. eCollection 2013.

45.
46.

A national outbreak of Salmonella serotype Tennessee infections from contaminated peanut butter: a new food vehicle for salmonellosis in the United States.

Sheth AN, Hoekstra M, Patel N, Ewald G, Lord C, Clarke C, Villamil E, Niksich K, Bopp C, Nguyen TA, Zink D, Lynch M.

Clin Infect Dis. 2011 Aug;53(4):356-62. doi: 10.1093/cid/cir407.

PMID:
21810748
47.

Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.

Sheth AN, Patel P, Peters PJ.

Curr HIV/AIDS Rep. 2011 Sep;8(3):181-91. doi: 10.1007/s11904-011-0086-4. Review.

PMID:
21710214
48.

High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States.

Hochberg NS, Moro RN, Sheth AN, Montgomery SP, Steurer F, McAuliffe IT, Wang YF, Armstrong W, Rivera HN, Lennox JL, Franco-Paredes C.

PLoS Negl Trop Dis. 2011 Apr 12;5(4):e1034. doi: 10.1371/journal.pntd.0001034.

49.

Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Sheth AN, Althoff KN, Brooks JT.

Clin Infect Dis. 2011 Jan 15;52(2):219-27. doi: 10.1093/cid/ciq110. Review.

50.

Impact of the integration of water treatment and handwashing incentives with antenatal services on hygiene practices of pregnant women in Malawi.

Sheth AN, Russo ET, Menon M, Wannemuehler K, Weinger M, Kudzala AC, Tauzie B, Masuku HD, Msowoya TE, Quick R.

Am J Trop Med Hyg. 2010 Dec;83(6):1315-21. doi: 10.4269/ajtmh.2010.10-0211.

Supplemental Content

Loading ...
Support Center